Drug reference
strontium ranelate
Bone agent · Osteoporosis treatment
Bone agentOsteoporosis treatment
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Suppresses bone resorption as well as stimulates bone formation.
Indications
Osteoporosis (reserve drug for elderly women >75 years with osteoporotic fracture and intolerance to bisphosphonates)
Related guidelines
Ask House about strontium ranelate
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: KD Tripathi 7e·Updated: 2026-05-10